These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5404870)

  • 1. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA; de Bulhões F; Tuma M
    Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of arteriosclerosis by Atromid].
    Ayad H
    Rev Med Moyen Orient; 1967; 24(6):504-11. PubMed ID: 5264185
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relations between lipid and carbohydrate metabolism. Treatment with a normo-lipemic agent: Clofibrate].
    Plauchu M; Gleize J; Garcia I; Mamelle ; Bussy L
    Lyon Med; 1969 Jun; 221(26):1537-46. PubMed ID: 5363734
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML; Setty KR; Roy SB
    J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 8. [Currently used therapeutic agents for arteriosclerosis--with special reference to a protein anabolic hormone, clofibrate (C.P.I.B.)].
    Yasugi T; Sasa E
    Nihon Rinsho; 1970 May; 28(5):1470-4. PubMed ID: 4915308
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular symptomatic relief during administration of ethylchlorophenoxyisobutyrate (clofibrate).
    Albert M; Stansell MJ
    Metabolism; 1969 Aug; 18(8):635-45. PubMed ID: 4895062
    [No Abstract]   [Full Text] [Related]  

  • 10. [Currently used therapeutic agents for arteriosclerosis--with special reference ro a protein anabolic hormone, clofibrate (C.P.I.B.)].
    Yasugi T; Sasa E
    Nihon Rinsho; 1970 May; 28(5):1470-4. PubMed ID: 4916330
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of the antilipidogenic and hypolipidemic effects of Insoal in diabetics and atherosclerotics].
    Warembourg H; Jaillard J
    Lille Med; 1967 May; 12(4):Suppl:510-5. PubMed ID: 5619704
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of the effect of ethyl-alpha-p-chlorophenoxybutyrate (clofibrate) in the venous retinal thrombosis].
    Cioli S; Nizzola GM
    Ann Ottalmol Clin Ocul; 1970 Sep; 96(9):477-82. PubMed ID: 5519038
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arteriosclerosis with special reference to anticholesteremic agents].
    Murakami M; Sekimoto H; Nakada I; Takegoshi T; Iwaki N
    Naika; 1970 Jun; 25(6):1082-6. PubMed ID: 5431239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and therapeutic evaluation of simfibrate compared toclofibrate in atherosclerotic patients].
    De Rosa G; Savi L; De Rosa E; Pola P; Boni P
    Clin Ter; 1979 Feb; 88(3):267-79. PubMed ID: 376218
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term monitoring during clofibrate therapy.
    Vester JW; Sunder JH; Aarons JH; Danowski TS
    Clin Pharmacol Ther; 1970; 11(5):689-97. PubMed ID: 5460240
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of diabetes insipidus with clofibrate].
    Annee Endocrinol; 1971; 23():101-3. PubMed ID: 5562226
    [No Abstract]   [Full Text] [Related]  

  • 17. [The value of lipavlon in diabetic retinopathy].
    François P; Belervacque A; Turut P
    Bull Soc Ophtalmol Fr; 1970 Apr; 70(4):568-73. PubMed ID: 5474598
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of chlorophenoxy-isobutyric ester on platelet adhesiveness and aggregation in the patients with arteriosclerosis and diabetes mellitus].
    Yasunaga K
    Naika Hokan; 1969 Oct; 16(10):393-403. PubMed ID: 5391800
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic study of clofibrate during pituitrin-sensitive diabetes insipidus in children].
    de Gennes JL; Desbois JC; Marie J
    Ann Pediatr (Paris); 1970 Nov; 17(11):754-9. PubMed ID: 5484620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.